Trial Profile
Clinical Trials Insight: 700013055
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 18 May 2006
Price :
$35
*
At a glance
- Drugs Elocalcitol (Primary)
- Indications Benign prostatic hyperplasia; Overactive bladder; Prostatitis
- Focus Therapeutic Use
- Sponsors Cosmo Research & Development
- 18 May 2006 New trial record.